XSHE
002476
Market cap441mUSD
Oct 09, Last price
4.85CNY
1D
0.41%
1Q
7.30%
Jan 2017
-53.53%
IPO
-11.56%
Name
Shandong Polymer Biochemicals Co Ltd
Chart & performance
P/E
94.77
P/S
4.92
EPS
0.05
Div yield, %
0.21%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
-1.70%
Revenues
603m
+12.00%
Net income
31m
-44.46%
CFO
27m
-13.08%
Dividend
Jun 18, 20250.01 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shandong Newleaf Chemical Co., Ltd., together with its subsidiaries, produces and sells chemicals for oil and gas exploitation in China and internationally. The company offers monomers, surface active agent, and polymers. It also provides oil field stimulation and oil recovery technical services; and environmental protection water treatment products and technical services.
Key people
Feipeng Xu
Chief Financial Officer, Deputy General Manager · since 2017
Ke Xu
Deputy General Manager · since 2021
Shipeng Zhang
Deputy General Manager, Secretary of the Board · since 2019
Jia Chen
Director · since 2016
Ao Liu
Director · since 2019
Yu Luo
Director · since 2019
Xucheng Tao
Chairman of the Board · since 2021
Ruixin Xiong
Director · since 2019
Gang Zhao
General Manager, Director · since 2021
Ning Li
Independent Director · since 2019
Ruji Zhang
Independent Director · since 2016
Jizhou Zhang
Independent Director · since 2016
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||